Manmeet Soni is a seasoned executive who currently holds the positions of Chief Operating Officer (COO) and Chief Financial Officer (CFO) at Summit Therapeutics Inc., a biopharmaceutical company focused on developing novel therapies for infectious diseases and cancer. With a robust background in finance and operations within the life sciences industry, Soni has been instrumental in steering Summit Therapeutics towards growth and innovation. Prior to joining Summit, he held significant roles at other notable biotech firms, where he honed his skills in strategic planning, financial management, and operational efficiency. Soni's career trajectory is marked by a series of notable achievements. Before his tenure at Summit Therapeutics, he served as the CFO at Aimmune Therapeutics, where he played a pivotal role in the company's successful IPO and subsequent growth. His strategic vision and financial acumen were critical in navigating the company through various stages of development and commercialization. Additionally, Soni has held key financial positions at companies such as InterMune and Chiron, further solidifying his expertise in the biotech sector. His ability to drive financial performance while fostering a culture of innovation has made him a respected leader in the industry. In his dual role at Summit Therapeutics, Manmeet Soni is responsible for overseeing the company's financial strategies and operational activities. As COO, he ensures that the company's day-to-day operations align with its long-term strategic goals, while as CFO, he manages the financial planning and reporting processes. Under his leadership, Summit Therapeutics has continued to advance its pipeline of promising drug candidates, securing crucial investments and partnerships that are essential for the company's future success. Soni's comprehensive approach to leadership and his dedication to advancing healthcare solutions underscore his significant impact on Summit Therapeutics and the broader biopharmaceutical landscape.